A-013

(±)-Amphetamine-d₅ (deuterium label on side chain) solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®

• Formule empirique (notation de Hill): C₉D₅H₈N
• Numéro CAS: 136765-27-0
• Poids moléculaire : 140.24
• Numéro MDL: MFCD00673256
• Code UNSPSC : 41116107
• ID de substance PubChem : 329770576
• Nomenclature NACRES : NA.24

Propriétés

• Qualité: certified reference material
• Forme: liquid
• Caractéristiques: SNAP-N-SPIKE^®. SNAP-N-SHOOT^®
• Conditionnement: ampule of 1 mL
• Fabricant/nom de marque: Cerilliant^®
• drug control: Narcotic Licence Schedule A (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIB (Portugal)
• Concentration: 1.0 mg/mL in methanol
• Technique(s): gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• Application(s): forensics and toxicology
• Format: single component solution
• Température de stockage: −20°C
• Chaîne SMILES: [2H]C(N)(C([2H])([2H])[2H])C([2H])C1=CC=CC=C1
• InChI: 1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/i1D3,7D,8D
• Clé InChI: KWTSXDURSIMDCE-ZXZAAQOOSA-N

Description

Description générale

Amphetamine, a stimulant of the phenethylamine class, is found in ADHD-treatment drugs such as Adderall^®, Vyvanse^®, and ProCentra^®. Because of its stimulant effect, amphetamine is used recreationally as a performance-enhancer and illicit drug. This stable-labeled internal standard is suitable for quantitation of amphetamine levels in urine, serum, or plasma by LC/MS or GC/MS for urine drug testing, clinical toxicology, forensic analysis, or sports testing.

Application

• Pharmacokinetic studies: The utilization of (±)-Amphetamine-d5 in a UPLC-MS/MS method for rapid screening of psychoactive drugs in blood exemplifies its role in pharmacokinetic analysis, aiding in the understanding of drug metabolism and clearance rates in forensic and clinical settings (Barone et al., 2023).
• Forensic toxicology: In forensic analysis, (±)-Amphetamine-d5 serves as an internal standard for the accurate detection and quantification of amphetamines in complex biological matrices, enhancing the reliability of drug testing protocols in legal and medical investigations (Andersson et al., 2008).
• Drug abuse monitoring: The compound′s application in the detection of amphetamine and methamphetamine in seized tablets demonstrates its critical role in public health and safety efforts, particularly in areas with high incidences of drug abuse (Alhazmi et al., 2020).

Informations légales

Adderall is a registered trademark of Richwood Pharmaceutical Company, Inc.

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

ProCentra is a registered trademark of Outlook Pharmaceuticals, Inc.

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Vyvanse is a registered trademark of Shire, LLC

Informations sur la sécurité

• Pictogrammes: GHS02,GHS06,GHS08
• Mention d'avertissement: Danger
• Mentions de danger: H225,H301 + H311 + H331,H370
• Conseils de prudence: P210 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311
• Classification des risques: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• Organes cibles: Eyes
• Code de la classe de stockage: 3 - Flammable liquids
• Classe de danger pour l'eau (WGK): WGK 1
• Point d'éclair (°F): 49.5 °F - closed cup
• Point d'éclair (°C): 9.7 °C - closed cup